Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Gerlach

Showing results (21-30 of 149) with videos related to

Pageof 15
Sort By:
Attention Deficit and Hyperactivity Disorders|February 9, 2017
No genetic association between attention-deficit/hyperactivity disorder (ADHD) and Parkinson's disease in nine ADHD candidate SNPsJulia M Geissler, , Marcel Romanos, et al.
Environmental Health Perspectives|June 26, 2007
Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder?Susanne Walitza, Birgit Werner, Marcel Romanos, et al.
European Journal of Pharmacology|May 22, 2002
Biochemical and pharmacological characterization of 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline: a biologically relevant neurotoxin?Peter Riederer, Paul Foley, Gerhard Bringmann, et al.
Attention Deficit and Hyperactivity Disorders|March 25, 2011
Does the treatment of maternal attention deficit and hyperactivity disorder (ADHD) enhance the efficacy of a behavioural parent training for the treatment of their children's ADHD? Study protocol of a randomized controlled multicentre trailThomas Jans, Alexandra Philipsen, Erika Graf, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 27, 2004
Entacapone increases and prolongs the central effects of l-DOPA in the 6-hydroxydopamine-lesioned ratManfred Gerlach, Maarten van den Buuse, Charles Blaha, et al.
Molecular Pain|March 31, 2011
5-hydroxyindolacetic acid (5-HIAA), a main metabolite of serotonin, is responsible for complete Freund's adjuvant-induced thermal hyperalgesia in miceYong Chen, Florian Palm, Klaus-Peter Lesch, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 21, 2011
Olfaction in child and adolescent anorexia nervosaMartin Schecklmann, Christoph Pfannstiel, Andreas J Fallgatter, et al.
Journal of Neurology|January 29, 2005
New developments in diagnosis and treatment of Parkinson's disease--from basic science to clinical applicationsAlexander Storch, Anne Hofer, Rejko Krüger, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 22, 2011
Role of dopamine D3 and serotonin 5-HT 1A receptors in L: -DOPA-induced dyskinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinson's diseaseManfred Gerlach, Gerd D Bartoszyk, Peter Riederer, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 20, 2010
No increased chromosomal damage in L-DOPA-treated patients with Parkinson's disease: a pilot studyRajaraman Gnana Oli, Gholamreza Fazeli, Wilfried Kuhn, et al.
Pageof 15

Showing results (21-30 of 149) with videos related to

Sort By:
Pageof 15
Attention Deficit and Hyperactivity Disorders|February 9, 2017
No genetic association between attention-deficit/hyperactivity disorder (ADHD) and Parkinson's disease in nine ADHD candidate SNPsJulia M Geissler, , Marcel Romanos, et al.
Environmental Health Perspectives|June 26, 2007
Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder?Susanne Walitza, Birgit Werner, Marcel Romanos, et al.
European Journal of Pharmacology|May 22, 2002
Biochemical and pharmacological characterization of 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline: a biologically relevant neurotoxin?Peter Riederer, Paul Foley, Gerhard Bringmann, et al.
Attention Deficit and Hyperactivity Disorders|March 25, 2011
Does the treatment of maternal attention deficit and hyperactivity disorder (ADHD) enhance the efficacy of a behavioural parent training for the treatment of their children's ADHD? Study protocol of a randomized controlled multicentre trailThomas Jans, Alexandra Philipsen, Erika Graf, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 27, 2004
Entacapone increases and prolongs the central effects of l-DOPA in the 6-hydroxydopamine-lesioned ratManfred Gerlach, Maarten van den Buuse, Charles Blaha, et al.
Molecular Pain|March 31, 2011
5-hydroxyindolacetic acid (5-HIAA), a main metabolite of serotonin, is responsible for complete Freund's adjuvant-induced thermal hyperalgesia in miceYong Chen, Florian Palm, Klaus-Peter Lesch, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 21, 2011
Olfaction in child and adolescent anorexia nervosaMartin Schecklmann, Christoph Pfannstiel, Andreas J Fallgatter, et al.
Journal of Neurology|January 29, 2005
New developments in diagnosis and treatment of Parkinson's disease--from basic science to clinical applicationsAlexander Storch, Anne Hofer, Rejko Krüger, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 22, 2011
Role of dopamine D3 and serotonin 5-HT 1A receptors in L: -DOPA-induced dyskinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinson's diseaseManfred Gerlach, Gerd D Bartoszyk, Peter Riederer, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 20, 2010
No increased chromosomal damage in L-DOPA-treated patients with Parkinson's disease: a pilot studyRajaraman Gnana Oli, Gholamreza Fazeli, Wilfried Kuhn, et al.
Pageof 15